All eyes on a hurdle race for a SARS-CoV-2 vaccine
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
Vaccini anti-Covid-19, rafforzare l'immunità. L'articolo su Nature
New Omicron-specific vaccines offer similar protection to existing boosters
Vaccines for the twenty-first century society | Nature Reviews Immunology
The Rockefeller University » Natural infection versus vaccination: Differences in COVID antibody responses emerge
How to choose a COVID-19 vaccine booster shot
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021 | MMWR
World Health Organization (WHO) - You should still get the COVID-19 vaccine even if you've had a previous infection. The vaccine acts as a booster that strengthens the immune response. Learn more
The global booster rollout is slow and unequal
A 'mix and match' approach to SARS-CoV-2 vaccination | Nature Medicine
Omicron is supercharging the COVID vaccine booster debate
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Artificial Proteins Never Seen in the Natural World Are Becoming New COVID Vaccines and Medicines - Scientific American
New COVID jabs are coming — who should get them?
BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant | Nature Medicine
What are booster vaccinations?
Omicron, Natural Immunity, & Booster Dose
JCM | Free Full-Text | SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
New Omicron-specific vaccines offer similar protection to existing boosters
New Omicron-specific vaccines offer similar protection to existing boosters
COVID-19: Disease-induced (natural) immunity, vaccination or hybrid immunity? | Nebraska Medicine Omaha, NE
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates | Nature Communications
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination | Nature Medicine
Ten billion COVID vaccinations: world hits new milestone
